Rigshospitalet

Running trials

• Not yet recruiting

  Dose-Escalated Short-Course Proton Therapy for Locally Advanced Rectal Cancer

  NCT07903883· Source

• Recruiting

  Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360

  NCT07323316· Source

• Not yet recruiting

  PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors

  NCT07590726· Source

• Not yet recruiting

  Infarct Growth After Intravenous Tocilizumab in Adults With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy - ILLUMINATE

  NCT07870681· Phase 2/3· Source

• Recruiting

  Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer

  NCT07432802· Source

• Not yet recruiting

  RECAP-D

  2026-526685-25-00· Phase 2· Source

• Not yet recruiting

  The HYCORE1 Trial: Hybrid Revascularization Versus Coronary Artery Bypass Grafting

  NCT05504031· Source

• Recruiting

  A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

  NCT07647510· Phase 3· Source

• Not yet recruiting

  A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer

  NCT07455422· Source

• Recruiting

  Vascular Complications After Kidney Transplantation

  NCT07531966· Source

• Recruiting

  Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial

  NCT07478003· Phase 3· Source

• Recruiting

  Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration

  NCT07523620· Source

• Recruiting

  A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

  NCT07549321· Phase 2/3· Source

• Not yet recruiting

  Social and Physical Activity as Rehabilitation for Preschool Kids With Cancer

  NCT07213024· Source

• Not yet recruiting

  Prediction of Complications in Hepatic Tumors

  NCT07358975· Phase 4· Source

• Recruiting

  Sonoporation and Tumor Microenvironment Response in Colorectal Liver Metastases

  NCT07365527· Source

• Recruiting

  SchoolCare: A Social Intervention Introducing Telepresence Robots and School Navigation to Reduce School Fragmentation for Children Undergoing Cancer Treatment

  NCT07398677· Source

• Not yet recruiting

  Comparison of Available Standard Pulse Field Ablation Methods for Pulmonary Vein Isolation for Treatment of Atrial Fibrillation

  NCT07456540· Source

• Not yet recruiting

  Neurocognitive Deficit After Paediatric Transplantation: Understanding the Role of Environment and Physical Function

  NCT07408713· Source

• Not yet recruiting

  Study for the Identification of Subclinical Atrial Fibrillation In Patients With Significant Primary Mitral Regurgitation

  NCT07377799· Source

• Not yet recruiting

  Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis

  NCT07413081· Source

• Recruiting

  Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions

  NCT07343349· Source

• Recruiting

  A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  NCT07218380· Phase 3· Source

• Active, not recruiting

  BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF

  NCT07181590· Source

• Recruiting

  Evaluating Health Literacy, Expectations and Regrets in Patients Undergoing Major Abdominal Surgery for Malignant Disease

  NCT07450950· Source

• Recruiting

  A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  NCT07213804· Phase 3· Source

• Recruiting

  Optimized Expansion of the Implanted Transcatheter Aortic Valve

  NCT07042529· Source

• Recruiting

  Fluorescence-Guided Optimization of Sarcoma Margins

  NCT07134192· Source

• Active, not recruiting

  A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

  NCT07005128· Phase 3· Source

• Recruiting

  Microvascular Profiling of Nodules in the Thyroid Gland

  NCT07041307· Source

• Recruiting

  A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

  NCT06523374· Source

• Recruiting

  AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

  NCT07094113· Phase 1· Source

• Recruiting

  Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  NCT06937086· Phase 3· Source

• Recruiting

  Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  NCT06937099· Phase 3· Source

• Recruiting

  A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  NCT06852222· Phase 3· Source

• Recruiting

  the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY Disease

  NCT06776419· Source

• Recruiting

  A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

  NCT06644781· Phase 3· Source

• Recruiting

  Unilateral vs. Bilateral Lung Volume Reduction Surgery

  NCT07731958· Source

• Recruiting

  Feasibility and Safety of Exercise in Patients With Low-risk Myeloid Cancers and Precursor Conditions

  NCT06773871· Source

• Active, not recruiting

  REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure

  NCT06557798· Source

• Active, not recruiting

  DurAVR™ THV EU-EFS

  NCT06510855· Source

• Recruiting

  A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

  NCT06585774· Phase 3· Source

• Recruiting

  Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease

  NCT06805448· Phase 1/2· Source

• Recruiting

  Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  NCT06526195· Source

• Active, not recruiting

  Abbott Medical - VERITAS Study

  NCT06707688· Source

• Active, not recruiting

  Continuous Glucose Monitoring in Dialysis Patients With Diabetes

  NCT06641765· Source

• Recruiting

  A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record

  NCT06642272· Phase 4· Source

• Recruiting

  Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate

  NCT06405750· Source

• Recruiting

  Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

  NCT06252649· Phase 3· Source

• Recruiting

  Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

  NCT06082063· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers8 recruiting
• Heart failure8 recruiting
• Atrial fibrillation6 recruiting
• Lung cancer6 recruiting
• Colorectal cancer5 recruiting
• Coronary artery disease5 recruiting
• Stroke5 recruiting
• Chronic kidney disease4 recruiting
• High blood pressure4 recruiting
• Amyloidosis3 recruiting
• Gastric and esophageal cancer3 recruiting
• Sarcoma3 recruiting
• Type 2 diabetes3 recruiting
• Acute myeloid leukemia2 recruiting
• ANCA-associated vasculitis2 recruiting
• Bladder cancer2 recruiting
• Chronic myeloid leukaemia2 recruiting
• Fabry disease2 recruiting
• Head and neck cancer2 recruiting
• Myasthenia gravis2 recruiting
• Myelodysplastic syndromes2 recruiting
• Obesity2 recruiting
• Ovarian cancer2 recruiting
• Pancreatic cancer2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• COPD1 recruiting
• Crohn's disease1 recruiting
• Depression1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Glioblastoma1 recruiting
• Hepatitis B1 recruiting
• HIV1 recruiting
• Hodgkin lymphoma1 recruiting
• Liver and biliary tract cancer1 recruiting
• Melanoma1 recruiting
• Metastatic breast cancer1 recruiting
• Neuroblastoma1 recruiting
• Neuroendocrine tumours1 recruiting
• Prostate cancer1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Sickle cell disease1 recruiting
• Sjögren's disease1 recruiting
• Thalassaemia1 recruiting
• Type 1 diabetes1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Recruiting

  Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  NCT07648264· Phase 3· Source

• Completed

  Strength Training Exercises to Minimise Late Effects of Childhood Leukaemia or Lymphoma Among Adolescents

  NCT06299722· Source

• Completed

  Feasibility and Safety of Home Blood Count Measurement and Transfusions in Patients With Acute Myeloid Leukemia

  NCT07062250· Source

• Recruiting

  An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

  NCT06035120· Source

• Recruiting

  A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

  NCT06285318· Source

• Completed

  The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes

  NCT06426823· Source

• Completed

  Human Mitochondrial Stress-driven Obesity Resistance

  NCT06080568· Source

• Completed

  Human-AI Collaboration for Ultrasound Diagnosis of Thyroid Nodules - a Clinical Trial

  NCT06306599· Source

• Completed

  FAME II-10-year Follow-Up

  NCT06159231· Source

• Terminated

  Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders

  NCT07254988· Source

• Completed

  Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

  NCT05291091· Phase 2· Source

• Completed

  STAY-STRONG Study of Exercise Training During Chemotherapy

  NCT05556239· Source

• Completed

  SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes

  NCT05754814· Source

• Completed

  Chest dRain rEmoval intrAoperatively afTer thoracOscopic Wedge Resection

  NCT05358158· Source

• Terminated

  The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer.

  NCT05354856· Phase 4· Source

• Completed

  Portico Valve-in-Valve Retrospective Registry

  NCT05002088· Source

• Completed

  Study of WVE-003 in Patients With Huntington's Disease

  NCT05032196· Phase 1/2· Source

• Completed

  A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL

  NCT04876092· Phase 1· Source

• Completed

  Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy

  NCT04774198· Source

• Completed

  Exercise-induced Cardiac Adaptions in Rheumatoid Arthritis Patients During IL-6 vs. TNF Antibody Therapy

  NCT05215509· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Source

• Completed

  Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease

  NCT04579315· Source

• Completed

  Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer

  NCT04637464· Source

• Completed

  Direct HIS/LBB Pacing as an Alternative to Biventricular Pacing in Patients With HFrEF and a Typical LBBB.

  NCT04409119· Source

• Completed

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· Phase 3· Source

• Completed

  Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions

  NCT04253171· Source

• Withdrawn

  Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer

  NCT03806049· Phase 3· Source

• Completed

  Study of DF1001 in Patients With Advanced Solid Tumors

  NCT04143711· Phase 1/2· Source

• Completed

  Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris

  NCT03039751· Phase 2· Source

• Completed

  eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood Illness

  NCT04150120· Source

• Completed

  Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy

  NCT03740126· Source

• Completed

  Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma

  NCT03890952· Phase 2· Source

• Completed

  DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS

  NCT03280862· Source

• Completed

  A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

  NCT03301220· Phase 3· Source

• Completed

  Quality of Life the Danish Multiple Myeloma Patients

  NCT02892383· Source

• Completed

  Prehospital and Acute Phase Characteristics of Severe Spontaneous ICH

  NCT07739030· Source

• Completed

  AMPLATZER™ Amulet™ LAA Occluder Trial

  NCT02879448· Source

• Completed

  CardioMEMS HF System OUS Post Market Study

  NCT02954341· Source

• Completed

  An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer

  NCT02632409· Phase 3· Source

• Completed

  New Generation IGRA in Immunocompromised Individuals

  NCT02639936· Source

• Completed

  Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

  NCT02445885· Source

• Completed

  Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold

  NCT02539966· Source

• Completed

  Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

  NCT02283853· Phase 3· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· Phase 3· Source

• Completed

  A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

  NCT01897480· Phase 2· Source

• Completed

  ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

  NCT02078427· Source